Company ProfilePremium

PerkinElmer Inc

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
PerkinElmer Inc - Healthcare showcase

Year Founded & Workforce

1937

13,000 Employees

Industry

Healthcare

Services

SolutionsBiomarker Detection
P

PerkinElmer Inc Employee Contacts

93 verified contactsNames, job titles, seniority and locations

View Employee Contacts

PerkinElmer Inc Overview

Company Headquarters: US

Founded: 1937

Workforce: ~13,000

Company Address: PerkinElmer Inc, 331 Treble Cove Rd, Billerica, Massachusetts, 01862 US.

Contact Details: Product Sales: California (1-408-232-0653); Puerto Rico (1-787 783 3067); Connecticut (1-203-905-4600); Investor Relation Contact (ir@perkinelmer.com Tel: (781) 663 6900, Address: 940 Winter Street, Waltham, MA 02451 US)

Company Working: PerkinElmer Inc (PerkinElmer) is largely engaged in providing solutions to diagnostics, delivery, and analytical solutions markets. The company deals in creating innovative solutions for better and fast diagnosis of various health issues worldwide. It pioneers in scientific technologies for better detection, imaging, and informatics. The company serves its customers in over 150 countries. PerkinElmer has nearly 3,500 patents active and operates in clinical research, life sciences, food, environmental, and industrial markets.

Strategy

PerkinElmer is focused on expanding its healthcare business unit with new product developments and successful launches in the coming years. Apart from this, the company aims at enhancing its R&D capabilities by manufacturing innovative products. The company focuses on optimizing the cost of capital based on market conditions and invests in untapped markets. It strives to build an efficient capital structure and strong shareholder returns by enhancing its product portfolio.

Company Snapshot

$2,105M

Revenue

13,000

Employees

1937

Founded

US

Headquarters

SWOT Analysis

Strengths

  • Unique set of offerings for customers
  • Well developed distribution channel
  • Leading market position
  • Strong performance in drug discovery sales and informatics business
  • Focused marketing efforts
  • Successful product development incorporating innovation
  • Partnerships with healthcare providers
  • Growing adoption of company’s products
  • Successful product developments incorporating innovation
  • Partnerships with healthcare service providers
  • Growing ownership and popularity of company’s products

Weaknesses

  • The company sells products and accessories predominantly through its direct sales force. As a result, the use of distributors is generally limited to geographic regions where the company has no direct sales force.
  • Low presence in emerging markets
  • Dependent on individual suppliers for a number of precursor products, packaging materials, and finished goods
  • Do not introduce new products in a timely manner
  • No recent developments related to the market
  • Limited product line for scientific and medical instruments
  • Limited product line

Opportunities

  • Expanding its global products and services offering and maintaining superior product quality
  • Expansion of spectral CT products
  • Disposition of businesses and assets
  • Mergers and acquisitions to brace position in the market
  • Mergers and acquisitions to strengthen market position

Threats

  • Economic, political, and other risks associated with foreign operations could adversely affect the international sales and profitability
  • Changes in governmental regulations may reduce the demand for products or increase expenses.
  • Huge competition in the medical diagnostics industry
  • Volatility in exchange rates
  • High competition from other players can affect the company’s market share
  • High competition from other players affecting the company’s market share

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
May 2018AcquisitionPerkin Elmer acquired Shanghai Spectrum Instruments Co Ltd, a leading manufacturer of analytical instruments in China to expand its own analytical instrument offerings in China and other emerging countries. This acquisition also helped in enhancing the company’s research and development capabilities in the atomic absorption technology.

Product Offering

  • PerkinElmer Inc
    • Solutions
    • Biomarker Detection

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Revenue rose from USD 2,104.8 Mn in 2016 to USD 2,778 Mn in 2018.
PerkinElmer Inc — By Business Segment
Series (USD Mn)201620172018
Revenue2,104.82,2572,778

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.